Romosozumab to rebuild the foundations of bone strength
Crossref DOI link: https://doi.org/10.1038/nrrheum.2018.5
Published Online: 2018-01-25
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferrari, Serge L.
Text and Data Mining valid from 2018-01-25
Article History
First Online: 25 January 2018
Competing interests
: The author declares that he has received research funding and consultancy fees from Amgen, MSD and UCB.